Adjuvant endocrine therapy in premenopausal women with breast cancer.

about

Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation An update on the management of breast cancer in Africa.Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.

P2860

Q28066991-9179A547-0793-4096-BF2F-FA7F518D1967 Q30235608-18AB0508-A076-4FD9-A085-6A82B2EC5CCB Q55322511-AADB69D2-AE7D-4482-A6FE-AB95D8E60DCE

P2860

Adjuvant endocrine therapy in premenopausal women with breast cancer.

Item

http://www.wikidata.org/entity/Q36976772

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Adjuvant endocrine therapy in premenopausal women with breast cancer.

@en

type

Item

label

Adjuvant endocrine therapy in premenopausal women with breast cancer.

@en

prefLabel

Adjuvant endocrine therapy in premenopausal women with breast cancer.

@en

P1476

Adjuvant endocrine therapy in premenopausal women with breast cancer.

@en

P2093

N Lynn Henry

http://www.w3.org/2001/XMLSchema#string

P2860

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Premature menopause or early menopause: long-term health consequences

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.

P304

663-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kunal C Kadakia

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27058571

http://www.w3.org/2001/XMLSchema#string

P932

4896158

http://www.w3.org/2001/XMLSchema#string

Adjuvant endocrine therapy in premenopausal women with breast cancer.

about

P2860

P2860

Adjuvant endocrine therapy in premenopausal women with breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P932